UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 276

Sortiert nach

Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.756-760

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays

Journal of thrombosis and haemostasis, 2011-01, Vol.9 (1), p.133-139

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays

Journal of thrombosis and haemostasis, 2014-09, Vol.12 (9), p.1545-1553

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

Thrombosis and haemostasis, 2011, Vol.105 (2), p.371

2011

Link zum Volltext

Verfügbarkeit prüfen

Measuring factor IX activity of nonacog beta pegol with commercially available one‐stage clotting and chromogenic assay kits: a two‐center study

Journal of thrombosis and haemostasis, 2016-07, Vol.14 (7), p.1428-1435

2016

Link zum Volltext

Verfügbarkeit prüfen

Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-05, Vol.20 (s4), p.65-70

2014

Link zum Volltext

Verfügbarkeit prüfen

Considerations in the laboratory assessment of haemostasis

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-07, Vol.16 (s5), p.74-78

2010

Link zum Volltext

Verfügbarkeit prüfen

Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-01, Vol.19 (1), p.106-112

2013

Link zum Volltext

Verfügbarkeit prüfen

Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol

Journal of thrombosis and haemostasis, 2010-10, Vol.8 (10), p.2216-2223

2010

Link zum Volltext

Verfügbarkeit prüfen

Geographic distribution of the 20210 G to A prothrombin variant

Thrombosis and haemostasis, 1998-04, Vol.79 (4), p.706

1998

Link zum Volltext

Verfügbarkeit prüfen

A comparative in vitro evaluation of six von Willebrand factor concentrates

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-05, Vol.10 (3), p.243-249

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-11, Vol.21 (6), p.837-845

2015

Link zum Volltext

Verfügbarkeit prüfen

Minor stroke as singular manifestation of hereditary thrombotic thrombocytopenic purpura in a young man

International angiology, 2009-08, Vol.28 (4), p.336

2009

Link zum Volltext

Verfügbarkeit prüfen

Haemoglobin and red blood cell reference intervals during infancy

Archives of disease in childhood, 2022-04, Vol.107 (4), p.351

2022

Link zum Volltext

Verfügbarkeit prüfen

Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion

British journal of ophthalmology, 2003-03, Vol.87 (3), p.305-306

2003

Link zum Volltext

Verfügbarkeit prüfen

Co‐segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1

Journal of thrombosis and haemostasis, 2004-11, Vol.2 (11), p.1918-1923

2004

Link zum Volltext

Verfügbarkeit prüfen

Analytical considerations for free protein S assays in protein S deficiency

Thrombosis and haemostasis, 2001-11, Vol.86 (5), p.1144

2001

Link zum Volltext

Verfügbarkeit prüfen

Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system

Journal of thrombosis and haemostasis, 2003-03, Vol.1 (3), p.601-602

2003

Link zum Volltext

Verfügbarkeit prüfen

Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase‐1 activity

Journal of thrombosis and haemostasis, 2003-01, Vol.1 (1), p.196-197

2003

Link zum Volltext

Verfügbarkeit prüfen

Influence of endotoxin challenge on protein S and C4b‐binding protein in healthy subjects

Journal of thrombosis and haemostasis, 2006-03, Vol.4 (3), p.692-694

2006

Link zum Volltext

Verfügbarkeit prüfen

Novel subunit in C4b-binding protein required for protein S binding

The Journal of biological chemistry, 1988-09, Vol.263 (25), p.12759-12764

1988

Link zum Volltext

Verfügbarkeit prüfen

Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays

Scandinavian journal of clinical and laboratory investigation, 2018-11, Vol.78 (7-8), p.575-583

2018

Link zum Volltext

Verfügbarkeit prüfen

Rapid Detection of Apixaban by a ROTEM-Based Approach and Reversibility with Andexanet Alfa or DOAC-Stop

TH open : companion journal to thrombosis and haemostasis, 2022-07, Vol.6 (3), p.e238-e247

2022

Link zum Volltext

Verfügbarkeit prüfen

The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families

Blood, 1998-03, Vol.91 (6), p.2210-2211

1998

Link zum Volltext

Verfügbarkeit prüfen

Soluble Transferrin Receptor during infancy and reference intervals for the Roche Cobas platform

International journal of laboratory hematology, 2021-06, Vol.43 (3), p.378-386

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 276

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(165)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(159)
Life Sciences & Biomedicine
(149)
Humans
(129)
Medicin Och Hälsovetenskap
(94)
Medical And Health Sciences
(91)
Old Medline
(69)
Female
(64)
Clinical Medicine
(63)
Klinisk Medicin
(63)
Hematology
(59)
Male
(51)
Biological And Medical Sciences
(43)
Cardiovascular System & Cardiology
(38)
Peripheral Vascular Disease
(38)
Medical Sciences
(34)
Basic Medicine
(33)
Medicinska Och Farmaceutiska Grundvetenskaper
(33)
Physiology
(33)
Middle Aged
(32)
Adult
(31)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays

Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays

Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

Measuring factor IX activity of nonacog beta pegol with commercially available one‐stage clotting and chromogenic assay kits: a two‐center study

Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis

Considerations in the laboratory assessment of haemostasis

Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A

Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol

Geographic distribution of the 20210 G to A prothrombin variant

A comparative in vitro evaluation of six von Willebrand factor concentrates

Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method

Minor stroke as singular manifestation of hereditary thrombotic thrombocytopenic purpura in a young man

Haemoglobin and red blood cell reference intervals during infancy

Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion

Co‐segregation of the PROS1 locus and protein S deficiency in families having no detectable mutations in PROS1

Analytical considerations for free protein S assays in protein S deficiency

Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system

Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase‐1 activity

Influence of endotoxin challenge on protein S and C4b‐binding protein in healthy subjects

Novel subunit in C4b-binding protein required for protein S binding

Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays

Rapid Detection of Apixaban by a ROTEM-Based Approach and Reversibility with Andexanet Alfa or DOAC-Stop

The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families

Soluble Transferrin Receptor during infancy and reference intervals for the Roche Cobas platform

Suchergebnisse filtern